Data (Animal) In a combined fertility and embryofetal development study in rats, subcutaneous doses of 0.01, 0.03 and 0.09 mg/kg/day (0.1-, 0.4-, and 1.1-fold the MRHD) were administered to males for 4 weeks prior to and throughout mating and to females for 2 weeks prior to mating, and throughout organogenesis to Gestation Day 17
Retatrutide isnt approved or available in the UK, and wont be for some years
Aftercare Advice Avoid touching the area for up to 6 hours, wash with a mild soap
PlexusDx requires initial consultation with licensed clinicians who assess cardiovascular history, current medications, and baseline blood pressure before dispensing
If you are considering personalized weight loss options, especially with complex health considerations, we strongly encourage you to take our free assessment quiz
None of the 25 topically applied products listed semaglutide, tirzepatide, or another FDA-approved GLP-1 or GLP-1/GIP agonist as an active pharmaceutical ingredient